REFERENCIAS BIBLIOGRÁFICAS
1. Anguita E., Villegas A.,
Diaz-Mendiavilla J., Gonzales A., Del Potro E., Espinós D. 1998. Detection of bcr/abl
mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity
of detection?. Haemat. 83: 744-747.
2. Au WY, Lie AK, Ma SK, Wan TS, Liang R, Leung YH, Kwong YL. 2001. Philadelphia (Ph)
chromosome-positive chronic myeloid leukemia relapsing as Ph-negative leukemia after
allogenic bone marrow transplantation. Br L Haematol 114(2):365-368.
3. Bartram C., Klein A., Hagemeijer A. 1983. Translocation of the c-abl oncogene correlate
whit the presence of the Ph chromosome CML. Nature (Lond) 306: 277-280.
4. Crose C.M., Huebner K., Isobe M. 1987. Mapping of four distinct BCR related loci to
chromosome: order of BCR loci relative to CML and ALL breakpoints. Proc. Natl. Acad Sc¡.
USA. 84: 7174-7178.
5. Fioretos T. 1996. Molecular genetic studies of Ph-positive leukemias and the Bcr and
Abl genes. Clin Genet 2: 21.
6. Groffen J., Stephenson J., Heisterkamp N. 1984. Philadelphia chromosomal breakpoints
are clustered within a limited region, bcr, one chromosome 22. Cell 36: 93-99.
7. Groffen J., Heisterkamp N. 1987. The BCR/ABL hybrid gene. Baillieres Clin Haematol 1:
983-999.
8. Hagemeijer A. 1987. Chromosome abnormalities in CML. Baillieres Clin Haematol 1: 963-981.
9. Kitzis A., Brizard F., Dascalescu C., Chomel JC., Guilhot F., Brizard A. 2001.
Persistence of transcriptionally silent BCR-ABL rearrangement in chronic myeloid leukemia
patients in sustained complete cytogenetic remission. Leuk Lymphoma 42(5):933-944.
10. Kurzrock R., Gutterman J., Talpaz M. 1988. The molecular genetics of Ph+ leukemia. N.
Engl. J. Med. 319: 990-998.
11. Radich JP., Gooley T., Bryant E., Chauncey T., Clift R., Beppu L., Edmans S., Flowers
ME., Kerkof K., Nelson R., Appelbaum FR. 2001. The significance of bcr-abl molecular
detection in chronic myeloid leukemia patients "late" 18 months or more after
transplantation. Blood 98(6): 1701-1707.
12. Santucci M., Saglio G., Tura S. 1996. Pathogenesis and progression of chronic myeloid
leukemia. Haemat 81: 63-76.
13. Sun B., Jiang G., Zaydan MA., La Russa VF., Safah H., Ehrlich M. 2001. ABL1 promoter
methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia
hematopoietic progenitors. Cancer Res 61(18): 6931-6937.
14. Van Etten R., Jackson R., Baltimore D. 1989. The mouse type 4 c-abl product is a
nuclear protein, and activation of transforming ability is associated with cytoplasmic
localization. Cell 58:669-678.
15. Vickers M. 1996. Estimation of the number of mutation necessary to cause chronic
myeloid leukemia from epidemiological data. Br J Haemat 94: 1-4.
Volver al
Artículo
|
